Targeting altered Nme heterooligomerization in disease?
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
November 27, 2017
|
| In: |
OncoTarget
Year: 2017, Jahrgang: 9, Heft: 2, Pages: 1492-1493 |
| ISSN: | 1949-2553 |
| DOI: | 10.18632/oncotarget.22716 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.18632/oncotarget.22716 Verlag, Volltext: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788576/ |
| Verfasserangaben: | Issam H. Abu-Taha, Christiane Vettel and Thomas Wieland |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1583675841 | ||
| 003 | DE-627 | ||
| 005 | 20230427193406.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 181113s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.18632/oncotarget.22716 |2 doi | |
| 035 | |a (DE-627)1583675841 | ||
| 035 | |a (DE-576)513675841 | ||
| 035 | |a (DE-599)BSZ513675841 | ||
| 035 | |a (OCoLC)1341022726 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Abu-Taha, Issam H. |d 1980- |e VerfasserIn |0 (DE-588)1026037328 |0 (DE-627)725955953 |0 (DE-576)371031222 |4 aut | |
| 245 | 1 | 0 | |a Targeting altered Nme heterooligomerization in disease? |c Issam H. Abu-Taha, Christiane Vettel and Thomas Wieland |
| 264 | 1 | |c November 27, 2017 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 13.11.2018 | ||
| 700 | 1 | |a Vettel, Christiane |d 1975- |e VerfasserIn |0 (DE-588)139395288 |0 (DE-627)610534734 |0 (DE-576)311522580 |4 aut | |
| 700 | 1 | |a Wieland, Thomas |d 1960-2025 |e VerfasserIn |0 (DE-588)1033445908 |0 (DE-627)741233215 |0 (DE-576)381043339 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t OncoTarget |d [Erscheinungsort nicht ermittelbar] : Impact Journals LLC, 2010 |g 9(2017), 2, Seite 1492-1493 |h Online-Ressource |w (DE-627)63035975X |w (DE-600)2560162-3 |w (DE-576)325343764 |x 1949-2553 |7 nnas |a Targeting altered Nme heterooligomerization in disease? |
| 773 | 1 | 8 | |g volume:9 |g year:2017 |g number:2 |g pages:1492-1493 |g extent:2 |a Targeting altered Nme heterooligomerization in disease? |
| 856 | 4 | 0 | |u http://dx.doi.org/10.18632/oncotarget.22716 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5788576/ |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20181113 | ||
| 993 | |a Article | ||
| 994 | |a 2017 | ||
| 998 | |g 1033445908 |a Wieland, Thomas |m 1033445908:Wieland, Thomas |d 60000 |d 65400 |e 60000PW1033445908 |e 65400PW1033445908 |k 0/60000/ |k 1/60000/65400/ |p 3 |y j | ||
| 998 | |g 139395288 |a Vettel, Christiane |m 139395288:Vettel, Christiane |d 60000 |d 65400 |e 60000PV139395288 |e 65400PV139395288 |k 0/60000/ |k 1/60000/65400/ |p 2 | ||
| 998 | |g 1026037328 |a Abu-Taha, Issam H. |m 1026037328:Abu-Taha, Issam H. |d 60000 |e 60000PA1026037328 |k 0/60000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1583675841 |e 3032137616 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1583675841","id":{"eki":["1583675841"],"doi":["10.18632/oncotarget.22716"]},"person":[{"display":"Abu-Taha, Issam H.","role":"aut","roleDisplay":"VerfasserIn","family":"Abu-Taha","given":"Issam H."},{"roleDisplay":"VerfasserIn","display":"Vettel, Christiane","role":"aut","given":"Christiane","family":"Vettel"},{"role":"aut","display":"Wieland, Thomas","roleDisplay":"VerfasserIn","given":"Thomas","family":"Wieland"}],"name":{"displayForm":["Issam H. Abu-Taha, Christiane Vettel and Thomas Wieland"]},"note":["Gesehen am 13.11.2018"],"physDesc":[{"extent":"2 S."}],"language":["eng"],"origin":[{"dateIssuedDisp":"November 27, 2017","dateIssuedKey":"2017"}],"relHost":[{"pubHistory":["1.2010,Mai -"],"note":["Gesehen am 16.08.2018"],"physDesc":[{"extent":"Online-Ressource"}],"recId":"63035975X","id":{"zdb":["2560162-3"],"issn":["1949-2553"],"eki":["63035975X"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2010-","publisherPlace":"[Erscheinungsort nicht ermittelbar]","dateIssuedKey":"2010","publisher":"Impact Journals LLC"}],"title":[{"title":"OncoTarget","title_sort":"OncoTarget","subtitle":"open access impact journal"}],"language":["eng"],"disp":"Targeting altered Nme heterooligomerization in disease?OncoTarget","part":{"issue":"2","year":"2017","volume":"9","extent":"2","pages":"1492-1493","text":"9(2017), 2, Seite 1492-1493"}}],"title":[{"title_sort":"Targeting altered Nme heterooligomerization in disease?","title":"Targeting altered Nme heterooligomerization in disease?"}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} | ||
| SRT | |a ABUTAHAISSTARGETINGA2720 | ||